Drawing for Serial No. 76510385

USPTO serial 76510385

Serial No. 76510385

Reviewed by CopyMark Law Group

Reg. 2965627Status 710
Filing date
Status date
Registration date
Jul 12, 2005
Examiner
GAYNOR, BARBARA ANNE
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 76510385?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

P. Jay Hines

P JAY HINES BAKER & HOSTETLER LLP1050 CONNECTICUT AVE NWASHINGTON SQUARE SUITE 1100WASHINGTON, DC 20036-5304

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment or prevention of Alzheimer's disease, Parkinson's disease, motor neurone disease, inflammatory diseases, eczema, asthma, obesity and metabolic syndrome; veterinary preparations for the treatment of canine osteoarthritis, canine atopic dermatitis and obesity; pharmaceutical preparations for the prevention and treatment of metabolic disorders, neural and muscular degeneration, [ determatological ] * dermatological * diseases and disorders, inflammatory diseases and disorders; veterinary preparations for domestic and farm animals for the prevention and treatment of metabolic disorders, neural and muscular degeneration, dermatological diseases and disorders, inflammatory diseases and disorders; pharmaceutical preparations for neuroprotection; veterinary preparations for domestic and farm animals for neuroprotection; plant extracts for pharmaceutical use, namely, phytochemical extracts; plant extracts for veterinary use on domestic and farm animals, namely, phytochemical extractsSECTION 8 - CANCELLED—
040Custom manufacture of pharmaceutical and veterinary preparations; custom manufacture of pharmaceutical and veterinary preparations for use in the prevention and treatment of metabolic disorders, neural and muscular degeneration, [ determatological ] * dermatological * diseases and disorders, inflammatory diseases and disorders; custom manufacture of pharmaceutical and veterinary preparations for neuroprotection; custom manufacture of plant extracts for pharmaceutical and veterinary useSECTION 8 - CANCELLED—
042Research and development for others of pharmaceutical and veterinary preparations and products; research and development for others of pharmaceutical and veterinary preparations and products for the prevention and treatment of metabolic disorders, neural and muscular degeneration, dermatological diseases and disorders, inflammatory diseases and disorders; research and development for others of pharmaceutical and veterinary preparations and products for neuroprotection; research and development for others of pharmaceutical and veterinary preparations and products for neuroprotection; research and development for others of plant extracts for pharmaceutical and veterinary useSECTION 8 - CANCELLED—
044Consulting services in the field of pharmaceutical and veterinary products, namely for the treatment of metabolic diseases and disorders, neural and muscular degenerative diseases and disorders, dermatological diseases and disorders, inflammatory diseases and disorders; consulting services in the field of plant extracts for pharmaceutical and veterinary useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 17, 2012C8..CANCELLED SEC. 8 (6-YR)—
Nov 26, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 28, 2007COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Apr 20, 2007PLGLASSIGNED TO PARALEGAL—
Mar 29, 2007AMD7SEC 7 REQUEST FILED—
Mar 29, 2007MAILPAPER RECEIVED—
Jul 12, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 27, 2005DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 31, 2005IUCNNOTICE OF ALLOWANCE CANCELLED—
Mar 31, 2005MAILPAPER RECEIVED—
Oct 12, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 20, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2004NPUBNOTICE OF PUBLICATION—
Apr 26, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2004CNEAEXAMINERS AMENDMENT MAILED—
Mar 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2004MAILPAPER RECEIVED—
Sep 30, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2003DOCKASSIGNED TO EXAMINER—
Aug 13, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2003MAILPAPER RECEIVED—

Frequently asked questions

Related guidance